Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
Crossref DOI link: https://doi.org/10.1007/s13300-018-0543-9
Published Online: 2018-12-05
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Balijepalli, Chakrapani
Shirali, Rohan
Kandaswamy, Prashanth
Ustyugova, Anastasia
Pfarr, Egon
Lund, Søren S.
Druyts, Eric
Article History
First Online: 5 December 2018